OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
13.43
+0.31 (2.36%)
At close: Jul 3, 2025, 1:00 PM
13.45
+0.02 (0.15%)
After-hours: Jul 3, 2025, 1:14 PM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $248.39 million as of July 3, 2025. Its market cap has increased by 24.26% in one year.
Market Cap
248.39M
Enterprise Value
264.62M
1-Year Change
24.26%
Ranking
Category
Stock Price
$13.43
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $248.39M, an increase of 626.28%. That is a compound annual growth rate of 32.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 248.40M | 177.54% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |